Orlistat may also be better for patients with heart conditions such as arrhythmias
doi: 10.1016/j.diabres.2017.01.012 5 SzadkowskaAMadejAZiolkowskaKSzymanskaMJeziornyKMianowskaBet al
( E ) Protein expression of nuclear factor (NF)-B, * vs
Recently, weve seen an increasing number of studies that show allulose, a low-carb and low-calorie sweetener, can trigger the release of GLP-1, the same hormone that promotes weight loss and stabilizes blood sugar
Buoyed by these results, Galmed Pharmaceuticals started, one year later, their 52-week Phase 3/4 ARMOR study (ClinicalTrials.gov NCT04104321) with NASH patients with advanced fibrosis (CRN stage 2 or 3) to evaluate the efficacy of Aramchol on NASH resolution, fibrosis improvement and a series of clinical outcomes related to NASH progression (Figure 1)
Adverse reactions or suspected defective products should be reported to the MHRA via the Yellow Card scheme